SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133672
Filing Date
2022-04-29
Accepted
2022-04-29 16:11:54
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d307415ddefa14a.htm DEFA14A 11575
2 GRAPHIC g307415g39p28.jpg GRAPHIC 406553
3 GRAPHIC g307415g40p37.jpg GRAPHIC 226386
  Complete submission text file 0001193125-22-133672.txt   884582
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39634 | Film No.: 22875464
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences